Epigenetics, Autism Spectrum, and Neurodevelopmental Disorders

Overview

Journal Neurotherapeutics

Specialty Neurology

Date 2013 Oct 10

PMID 24104594

Citations 46

Authors

Sampathkumar Rangasamy

Santosh R DMello

Vinodh Narayanan

Affiliations

Soon will be listed here.

Abstract

Epigenetic marks are modifications of DNA and histones. They are considered to be permanent within a single cell during development, and are heritable across cell division. Programming of neurons through epigenetic mechanisms is believed to be critical in neural development. Disruption or alteration in this process causes an array of neurodevelopmental disorders, including autism spectrum disorders (ASDs). Recent studies have provided evidence for an altered epigenetic landscape in ASDs and demonstrated the central role of epigenetic mechanisms in their pathogenesis. Many of the genes linked to the ASDs encode proteins that are involved in transcriptional regulation and chromatin remodeling. In this review we highlight selected neurodevelopmental disorders in which epigenetic dysregulation plays an important role. These include Rett syndrome, fragile X syndrome, Prader-Willi syndrome, Angelman syndrome, and Kabuki syndrome. For each of these disorders, we discuss how advances in our understanding of epigenetic mechanisms may lead to novel therapeutic approaches.

Citing Articles

Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome.

Borrego-Ruiz A, Borrego J Genes (Basel). 2025; 15(12.

PMID: 39766866 PMC: 11675900. DOI: 10.3390/genes15121599.

Unraveling the relative abundance of psychobiotic bacteria in children with Autism Spectrum Disorder.

Darwesh M, Bakr W, Omar T, El-Kholy M, Azzam N Sci Rep. 2024; 14(1):24321.

PMID: 39414875 PMC: 11484847. DOI: 10.1038/s41598-024-72962-3.

SETD5 haploinsufficiency affects mitochondrial compartment in neural cells.

Zaghi M, Longo F, Massimino L, Rubio A, Bido S, Mazzara P Mol Autism. 2023; 14(1):20.

PMID: 37264456 PMC: 10233863. DOI: 10.1186/s13229-023-00550-9.

Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice.

Sheppard S, Bryant L, Wickramasekara R, Vaccaro C, Robertson B, Hallgren J Sci Adv. 2023; 9(10):eade1463.

PMID: 36897941 PMC: 10005179. DOI: 10.1126/sciadv.ade1463.

Evidence for parent-of-origin effects in autism spectrum disorder: a narrative review.

Ryan N, Heron E J Appl Genet. 2023; 64(2):303-317.

PMID: 36710277 PMC: 10076404. DOI: 10.1007/s13353-022-00742-8.

References

Torrioli M, Vernacotola S, Setini C, Bevilacqua F, Martinelli D, Snape M . Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys. Am J Med Genet A. 2010; 152A(6):1420-7. DOI: 10.1002/ajmg.a.33484. View

Baker J, Seltzer M, Greenberg J . Behaviour problems, maternal internalising symptoms and family relations in families of adolescents and adults with fragile X syndrome. J Intellect Disabil Res. 2012; 56(10):984-95. PMC: 3443295. DOI: 10.1111/j.1365-2788.2012.01580.x. View

Bauman M, Kemper T, Arin D . Microscopic observations of the brain in Rett syndrome. Neuropediatrics. 1995; 26(2):105-8. DOI: 10.1055/s-2007-979737. View

Lugtenberg D, Kleefstra T, Oudakker A, Nillesen W, Yntema H, Tzschach A . Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur J Hum Genet. 2008; 17(4):444-53. PMC: 2986218. DOI: 10.1038/ejhg.2008.208. View

Mellen M, Ayata P, Dewell S, Kriaucionis S, Heintz N . MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012; 151(7):1417-30. PMC: 3653293. DOI: 10.1016/j.cell.2012.11.022. View

Belichenko P, Oldfors A, Hagberg B, Dahlstrom A . Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport. 1994; 5(12):1509-13. View

Gross C, Berry-Kravis E, Bassell G . Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology. 2011; 37(1):178-95. PMC: 3238060. DOI: 10.1038/npp.2011.137. View

Dunn H, Macleod P . Rett syndrome: review of biological abnormalities. Can J Neurol Sci. 2001; 28(1):16-29. DOI: 10.1017/s0317167100052513. View

Rauch C, Trieb M, Wibowo F, Wellenzohn B, Mayer E, Liedl K . Towards an understanding of DNA recognition by the methyl-CpG binding domain 1. J Biomol Struct Dyn. 2005; 22(6):695-706. DOI: 10.1080/07391102.2005.10507036. View

10.

Jentarra G, Olfers S, Rice S, Srivastava N, Homanics G, Blue M . Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci. 2010; 11:19. PMC: 2836362. DOI: 10.1186/1471-2202-11-19. View

11.

Chahrour M, Jung S, Shaw C, Zhou X, Wong S, Qin J . MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008; 320(5880):1224-9. PMC: 2443785. DOI: 10.1126/science.1153252. View

12.

Horike S, Cai S, Miyano M, Cheng J, Kohwi-Shigematsu T . Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet. 2004; 37(1):31-40. DOI: 10.1038/ng1491. View

13.

Banka S, Veeramachaneni R, Reardon W, Howard E, Bunstone S, Ragge N . How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet. 2011; 20(4):381-8. PMC: 3306863. DOI: 10.1038/ejhg.2011.220. View

14.

Urbach A, Bar-Nur O, Daley G, Benvenisty N . Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell. 2010; 6(5):407-11. PMC: 3354574. DOI: 10.1016/j.stem.2010.04.005. View

15.

Smith S, Zhou Y, Zhang G, Jin Z, Stoppel D, Anderson M . Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med. 2011; 3(103):103ra97. PMC: 3356696. DOI: 10.1126/scitranslmed.3002627. View

16.

Lorincz M, Dickerson D, Schmitt M, Groudine M . Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol. 2004; 11(11):1068-75. DOI: 10.1038/nsmb840. View

17.

Rougeulle C, Cardoso C, Fontes M, Colleaux L, Lalande M . An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat Genet. 1998; 19(1):15-6. DOI: 10.1038/ng0598-15. View

18.

Nan X, Ng H, Johnson C, Laherty C, Turner B, Eisenman R . Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998; 393(6683):386-9. DOI: 10.1038/30764. View

19.

Bokinni Y . Kabuki syndrome revisited. J Hum Genet. 2012; 57(4):223-7. DOI: 10.1038/jhg.2012.28. View

20.

Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T . Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981; 99(4):565-9. DOI: 10.1016/s0022-3476(81)80255-7. View